Liver Biopsy Microarray

This data represents gene expression from genotype 1 HCV infected liver biopsies using an Illumina microarray. All data has been normalized

Distribution of HLA-alleles at study entry.

<p>Distribution of HLA-alleles at study entry.</p

Long-term follow up and patient disposition in the Bonn HIV and HCV cohort.

<p>Long-term follow up and patient disposition in the Bonn HIV and HCV cohort.</p

Independent risk factors for all-cause-mortality in all HIV positive patients.

<p>Independent risk factors for all-cause-mortality in all HIV positive patients.</p

All-cause survival analysis stratified with respect to HLA-B*57.

<p>This figure shows Kaplan-Meier plots comparing all-cause-survival between HLA-B*57-positive (green lines) and HLA-B*57-negative patients (blue lines) in all HIV-infected patients (Fig 2A), and separately in the HIV-infected patients with (Fig 2B) and without HCV co-infection (Fig 2C). Vertical marks indicate censored patients. The Log-rank test was used to test statistical significances.</p

Clinical features of the HLA-B*57-positive patients who had died.

<p>Clinical features of the HLA-B*57-positive patients who had died.</p

Patient Characteristics in the Study Population.

<p>Patient Characteristics in the Study Population.</p

Independent risk factors for all-cause-mortality in HIV and HCV positive patients.

<p>Independent risk factors for all-cause-mortality in HIV and HCV positive patients.</p